News and Updates

We believe in greater communication with you.

PeproTech, now a part of Thermo Fisher Scientific, is committed to providing you with regular news and updates. Though our email addresses have changed, you can be assured we will provide the same quality products, transparent customer communication, and personalized technical service to support your next scientific breakthrough.

We believe in greater support:

Contact your regional Customer Service, Technical Support Expert or Sales Rep for personalized support backed by the same technical expertise you’ve grown accustomed to.

We believe in greater scientific excellence:

Check out our FAQ page product-related questions that may arise during the use of our signature protein products.

January 2023

PeproTech Manufacturing Facility Update

You’ve been an incredible partner of ours, so we’re thrilled to share a pivotal moment of continued growth for our PeproTech portfolio that will help us make an even greater impact on the scientific community.

In March 2020, we relocated our corporate headquarters and New Jersey manufacturing to Cranbury, NJ, to a state-of-the-art, 65,000 square foot facility. Then in 2021, PeproTech became a part of Thermo Fisher Scientific. As a part of Thermo Fisher Scientific, we are now taking the next step in partnership and growth as we are expanding our footprint in Cranbury, NJ, to bring all our recombinant protein production to one Center of Excellence. With the relocation of our Animal-Free E. coli-derived proteins manufactured at the Westlake Village, CA, facility to Cranbury, NJ, this allows us to house every facet of our business in one location, while continuing to offer customers like you unmatched cellular therapy products and support. In addition to creating this expansive Recombinant Protein Center of Excellence, this relocation will allow for increased production capacity to better suit your needs and timing. As you explore new technologies, we’ll be by your side at the forefront of research, ready to grow in our new facility at pace with our ever-evolving industry.

We want to express our sincere gratitude for your partnership. While we’re excited to continue growing on a global scale, we remain steadfast in our commitment to providing you with the personalized support you’d expect from a local, trusted partner. Your success is our top priority.

If you have any questions or want to learn more about our enhanced capabilities, don’t hesitate to reach out at [email protected] or (800)436-9910 anytime. We’re here for you today and looking forward to the discoveries ahead. 

November 2022

PeproTech Email Address Update

In December 2021, Thermo Fisher Scientific acquired PeproTech. As part of on-going integration, teams within Thermo Fisher are also working diligently to ensure systems and processes are aligned for optimal operation as well. To ensure minimal disruption to our customers, we are proactively notifying you of upcoming changes to PeproTech colleague email address nomenclature.

Effective 15th November, emails coming from your PeproTech partners will now be coming from a email address. This change also includes customer service and technical support general email addresses as well.

Currently PeproTech email addresses are formatted as: first initial last name (i.e. [email protected] for Kevin Smith). After the change, it will be [email protected] (i.e. [email protected] for Brian Jones).

Additionally, for general email boxes, the email nomenclature format will change from [email protected] to [email protected].

Example: [email protected] will now be [email protected].

We would encourage you to update your address book for relevant PeproTech contacts. We are also ensuring continuous service by automatically forwarding all emails received to PeproTech email addresses following 15th November to the corresponding new Thermo Fisher email address. There is currently no plan for discontinuation of the PeproTech email addresses for receiving email correspondence, so rest assured that your emails will continue to be received regardless of the address used.

As always, our top priority is providing the best possible service to our customers, so if there is any issue or question that you may have through this transition, please do not hesitate to reach out to our team for support. They can be reached at +44 (0)20 7610 3062 and [email protected].

Thank you for joining us on this exciting journey to further supporting your discoveries by expanding our capabilities in serving you. 

August 2022

Introducing: PeproGMP® Recombinant Human BMP-4

We are excited to further support your discoveries with the introduction of the PeproGMP® BMP-4 cytokine. With this addition to the already existing RUO and animal origin-free BMP-4 cytokines, we can better support the transition from lab to clinic.

Consistent with federal requirements and best practices for cell therapy, gene therapy, and tissue-engineered products for clinical applications, PeproGMP® Human BMP-4 is manufactured and tested in compliance with relevant US FDA cGMP (Good Manufacturing Practices) regulations and the ISO 9001 quality management systems standard, without the use of animal-derived materials.

When you purchase PeproGMP® products, you are getting much more than a cytokine product, you are getting a personalized team of experts to support you through your next cell therapy or tissue engineering break-through.

January 2022

PeproTech is now part of Thermo Fisher Scientific

Our high quality recombinant protein portfolio joins Thermo Fisher Scientific, the world leader in serving science. Together, we provide a more comprehensive offering to our customers to accelerate life science research.